Charting the course for US innovation.

This episode features partners Mark Davies and Sapna Palla in a discussion about the new administration’s likely approach to IP law. Mark focuses on appellate litigation for technology companies. Sapna handles all types of litigation for clients in the life sciences sector. Topics covered in this episode include developments at the US Patent and Trademark Office, possible implications for patents that rely on AI, potential tariffs on pharmaceuticals, trends in patent litigation and the fate of key bipartisan patent reform bills introduced during the Biden administration.

For more insights and related content from our lawyers, please visit our US Administration Tracker. 

Send questions and feedback to podcastfeedback@whitecase.com

White & Case means the international legal practice comprising White & Case LLP, a New York State registered limited liability partnership, White & Case LLP, a limited liability partnership incorporated under English law and all other affiliated partnerships, companies and entities.

This podcast is prepared for the general information of interested persons. It is not, and does not attempt to be, comprehensive in nature. Due to the general nature of its content, it should not be regarded as legal advice.